$516.56
3.350.65%
가까이에: Sep 25, 5:00 PM EST
$516.56
N/A
시간외: 4:40 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 26
Madrigal Pharmaceuticals Inc
MDGLNASDAQ
Madrigal Pharmaceuticals Earnings & Forecasts
Madrigal Pharmaceuticals (MDGL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Madrigal Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.32 | $-4.04 | $-0.52 | $-1.99 |
| Actual | $-1.99 | $-3.25 | $-2.57 | $-5.08 |
| Surprise | +14.2% | +19.6% | -394.2% | -155.3% |
| Revenue | ||||
| Estimate | $349.6M | $301.0M | $313.0M | $247.2M |
| Actual | $364.3M | $311.3M | $321.1M | $287.3M |
| Surprise | +4.18% | +3.44% | +2.58% | +16.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.07 | $-0.45 | $-1.83 | $0.72 |
| Revenue | ||||
| Consensus | $404.2M | $445.0M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved